• Home
  • About Us
    • Company
    • Leadership
    • Board of Directors
    • Board of Advisors
  • Proton Therapy
  • Technology
  • News & Media
  • Careers
  • Contact Us
  • Invest
Menu
  • Home
  • About Us
    • Company
    • Leadership
    • Board of Directors
    • Board of Advisors
  • Proton Therapy
  • Technology
  • News & Media
  • Careers
  • Contact Us
  • Invest

Home / News & Media

A Consortium led by HIL wins major R&D grant by European Union

A Consortium led by HIL wins major R&D grant by European Union The European Commission managing Horizon 2020 – the EU Framework Program for Research

Continue reading »
July 27, 2020

Dr. Ehud (Udi) Netzer is named Chairman at HIL

Dr. Ehud (Udi) Netzer is named Chairman at HIL. Dr. Netzer joined HIL’s Board of Directors last year and was today appointed by HIL’s Board

Continue reading »
April 26, 2020

We’re on the Map! HIL featured in The Marker Magazine STARTUP NATION HIGH-TECH MAP:

We’re on the Map! HIL featured in The Marker Magazine STARTUP NATION HIGH-TECH MAP: The Marker magazine tells the story of HIL Applied Medical and its unique Proton

Continue reading »
February 3, 2020

HIL at JP Morgan Healthcare Conference – the CICC Israel Lounge

HIL at JP Morgan Healthcare Conference – the CICC Israel Lounge   HIL will partake in the CICC’s Israel Lounge, on January 13-14th, during the JP Morgan

Continue reading »
December 12, 2019

HIL awarded €2.5M in grant funding by the EU

HIL awarded €2.5M in grant funding by the EU The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation –

Continue reading »
July 31, 2019

Dr. Raphael Pfeffer, Assuta Chief Of Oncology and HIL Advisory Board Member, in an interview on the future of radiation therapy

Dr. Raphael Pfeffer, Assuta Chief Of Oncology and HIL Advisory Board Member, in an interview on the future of radiation therapy  For its Medicine 2020

Continue reading »
June 27, 2019

Dr. Ehud (Udi) Netzer joins HIL’s Board of Directors

Dr. Ehud (Udi) Netzer joins HIL’s Board of Directors Dr. Netzer is a seasoned technology leader with over 35 years of experience covering all phases

Continue reading »
June 24, 2019

HIL and CERN enter collaboration (and Globes coverage)

HIL and CERN announce collaboration (and Globes coverage) Novel technologies developed at CERN could be used in HIL’s system, helping to further reduce the size

Continue reading »
April 18, 2019

HIL and Hebrew University announce new R&D and manufacturing facility in Jerusalem

HIL and Hebrew University announce new R&D and manufacturing facility in Jerusalem Calcalist, one of Israel’s leading financial news outlets, published HIL’s plan to set

Continue reading »
March 17, 2019

HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report

HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report HIL is featured as one of 160 companies in the Aging Analytics Agency and

Continue reading »
March 17, 2019
Page1 Page2 Page3 Page4 Page5

Copyright 2010-2021 HIL Applied Medical (C) All rights reserved. Design by Romi-G | Code by Digital Guru

  • Home
  • About Us
    • Company
    • Leadership
    • Board of Directors
    • Board of Advisors
  • Proton Therapy
  • Technology
  • News & Media
  • Careers
  • Contact Us
  • Invest
Menu
  • Home
  • About Us
    • Company
    • Leadership
    • Board of Directors
    • Board of Advisors
  • Proton Therapy
  • Technology
  • News & Media
  • Careers
  • Contact Us
  • Invest